RSSScience & Technology

Professor named to Forbes’ ‘30 Under 30’ in science

Professor named to Forbes’ ‘30 Under 30’ in science

January 23, 2015

Each year, Forbes Magazine lists the top 30 people under the age of 30 who have reached notable success in their chosen field. Elika Bergelson, a research assistant professor in the Department of Brain and Cognitive Sciences, was selected for the 2015 list for her work on the development of language in infants.

Continue Reading

Daniel Weix to receive a Novartis Early Career Award

Daniel Weix to receive a Novartis Early Career Award

January 15, 2015

Novartis, a multi-national pharmaceutical company based in Switzerland, honors two scientists each year who are “within 10 years of having established an independent academic research career in the areas of organic or bioorganic chemistry in the broadest sense.” The Novartis Early Career Award comes with a $150,000 grant over three years to continue the recipient’s research.

Continue Reading

UR testing HIV vaccine pill

UR testing HIV vaccine pill

January 13, 2015

Researchers hope that this oral vaccine will create a more robust immune response against HIV. Volunteer study subjects must be between the ages of 18 and 40, in good health and not infected with HIV; they will be paid up to $2,050 based on their level of participation.

Continue Reading

Neurologists rank Alzheimer’s agitation study in Top 10 of 2014

Neurologists rank Alzheimer’s agitation study in Top 10 of 2014

January 12, 2015

The American Academy of Neurology has included a UR Medicine study among its picks for the most revolutionary research of 2014. The study found that a high dose of a common antidepressant drug significantly reduced agitation in Alzheimer’s disease patients.

Continue Reading

New study probes link between HIV drugs, vascular disease

New study probes link between HIV drugs, vascular disease

January 5, 2015

A new $3.8 million grant will bring together clinical and bench researchers to better understand why individuals who receive anti-retroviral treatment for HIV are at greater risk for heart disease and stroke.

Continue Reading

Researchers show neutrinos can deliver not only full-on hits but also ‘glancing blows’

Researchers show neutrinos can deliver not only full-on hits but also ‘glancing blows’

December 30, 2014

In what they call a “weird little corner” of the already weird world of neutrinos, physicists have found evidence that these tiny particles might be involved in a surprising reaction. In an experiment conducted with the international MINERvA collaboration at Fermilab, physics professor Kevin McFarland and his students and colleagues provide evidence that neutrinos can sometimes interact with a nucleus but leave it basically untouched, resulting in a new particle being created out of a vacuum.

Continue Reading

Researchers explain how our minds make sense through order

Researchers explain how our minds make sense through order

December 15, 2014

Rochester scientists say they have an alternative to the standard explanation for why order matters when the human mind processes information. Ting Qian and Richard Aslin explain that our tendency to detect patterns is built into our cognitive processes, even when it’s at the risk of overestimating the importance of such patterns. (photo by Flickr user redwoodphotography made available under CC BY-ND 2.0)

Continue Reading

Commonly prescribed drug for lower back pain not effective

Commonly prescribed drug for lower back pain not effective

December 12, 2014

A new Medical Center study shows that pregabalin — marketed under the name Lyrica — is not effective in controlling the pain associated with lumbar spinal stenosis, the most common type of chronic lower back pain in older adults.

Continue Reading

Decoding fat cells: Discovery may explain why we gain weight

Decoding fat cells: Discovery may explain why we gain weight

December 11, 2014

Medical Center researchers believe they’re on track to solve the mystery of weight gain – and it has nothing to do with holiday eggnog. They discovered that a protein, Thy1, has a fundamental role in controlling whether a primitive cell decides to become a fat cell, making Thy1 a possible therapeutic target in treating obesity.

Continue Reading

New imaging technique helps predict how vision recovers after brain tumor removal

New imaging technique helps predict how vision recovers after brain tumor removal

December 10, 2014

An interdisciplinary team of University neuroscientists and neurosurgeons has used a new imaging technique to show how the human brain heals itself in just a few weeks following surgical removal of a brain tumor.

Continue Reading

Optimization WordPress Plugins & Solutions by W3 EDGE